This Biotech is the First to Work on Antivirals for Farm Livestock
While in Leuven, Belgium, for last week’s Biotech of the Week, we decided to go…
12/10/2018 - 3 minutes
Belgium
Update: Series A Boost Pushes Belgian Microbiome Spin-Off Forward
Update (27/09/2018): New investment from Dutch venture capital fund Innovation Industries brings A-Mansia's Series A…
27/09/2018 - 2 minutes
Cell Therapy Helps Regenerate Difficult Bone Fractures
All patients in a clinical trial run by the Belgian company Bone Therapeutics have seen…
14/09/2018 - 2 minutes
The EMA Approves the First Nanobody from Ablynx
Update: The EMA has officially approved Cablivi for the treatment of adults with acquired thrombotic thrombocytopenic…
04/09/2018 - 2 minutes
Belgian Biotech Completes First Trial with New Drug for Diabetic Macular Edema
Belgian biotech ThromboGenics has conducted the first clinical trial of an antibody to treat one of…
20/07/2018 - 2 minutes
A New HIV Vaccine Could Protect Patients Against Multiple Viral Strains
A new HIV vaccine is moving into a Phase IIb trial and could potentially protect…
06/07/2018 - 2 minutes
Massive Series B Funding Could Bring Belgian Immuno-oncology Treatments Into the Clinic
iTeos Therapeutics raised €65M ($75M) to bring two of its cancer treatments into the clinic…
20/06/2018 - 2 minutes
The First In-Human Trial of an Eye Implant Helps Patients With Glaucoma
iSTAR Medical has obtained promising results from the first-in-human trial of an eye implant, that…
17/05/2018 - 2 minutes
“This is the First Time CAR-T Has Ever Worked on Acute Myeloid Leukemia“
Celyad has reported clinical results showing the first time a patient has fully recovered from…
19/04/2018 - 3 minutes
Cheese-Producing Bacteria Could Help Reverse Type 1 Diabetes
ActoBio Therapeutics has received permission from the FDA to start a clinical trial for a…
03/04/2018 - 2 minutes
Belgian Firm Raises €19M to Fix Spinal Fusion with Cell Therapy
Bone Therapeutics has raised €19.5M through a private placement that will fund the completion of…
08/03/2018 - 1 minute
ASIT Biotech Raises €13.9 M to Develop Allergy Immunotherapies
ASIT Biotech, a Belgian company specialized in allergy immunotherapy, raised a total of €13.9M to…
26/02/2018 - 3 minutes
